Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO10026 | Mitracarpus scaber | Species | Rubiaceae | Eukaryota | UNPD* | |||
NPO12682 | Euphorbia helioscopia | Species | Euphorbiaceae | Eukaryota | TCM_Taiwan* | |||
NPO1698 | Glycyrrhiza inflata | Species | Fabaceae | Eukaryota | TCM_Taiwan* | |||
NPO1698 | Glycyrrhiza inflata | Species | Fabaceae | Eukaryota | HerDing* | |||
NPO23019 | Glycyrrhiza kansuensis | Species | Fabaceae | Eukaryota | HerDing* | |||
NPO29384 | Glycyrrhiza glabra | Species | Fabaceae | Eukaryota | TCM_Taiwan* | |||
NPO29384 | Glycyrrhiza glabra | Species | Fabaceae | Eukaryota | HerDing* | |||
NPO7786 | Lentinus tigrinus | Species | Lentinaceae | Eukaryota | UNPD* | |||
NPO7154 | Glycyrrhiza uralensis | Species | Fabaceae | Eukaryota | UNPD* | |||
NPO15835 | Glycyrrhiza | Species | Fabaceae | Eukaryota | TCMSP* | |||
NPO29384 | Glycyrrhiza glabra | Species | Fabaceae | Eukaryota | TM-MC* | |||
NPO1698 | Glycyrrhiza inflata | Species | Fabaceae | Eukaryota | TM-MC* | |||
NPO7154 | Glycyrrhiza uralensis | Species | Fabaceae | Eukaryota | TM-MC* | |||
NPO29384 | Glycyrrhiza glabra | Species | Fabaceae | Eukaryota | TCMID* | |||
NPO1698 | Glycyrrhiza inflata | Species | Fabaceae | Eukaryota | TCMID* | |||
NPO23019 | Glycyrrhiza kansuensis | Species | Fabaceae | Eukaryota | TCMID* |
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT178 | Individual Protein | Protein-tyrosine phosphatase 1B | Homo sapiens | Inhibition | < | 50 | % | 24047800 |
NPT113 | Cell Line | RAW264.7 | Mus musculus | IC50 | = | 9940 | nM | 24316124 |
NPT113 | Cell Line | RAW264.7 | Mus musculus | Inhibition | = | 69.6 | % | 24316124 |
NPT113 | Cell Line | RAW264.7 | Mus musculus | Inhibition | = | 17.2 | % | 24316124 |
NPT2 | Others | Unspecified | IC50 | > | 30000 | nM | 24316124 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC110419 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.9926 | High Similarity | NPC312256 |
0.9781 | High Similarity | NPC207732 |
0.971 | High Similarity | NPC157133 |
0.9708 | High Similarity | NPC254659 |
0.964 | High Similarity | NPC165389 |
0.9638 | High Similarity | NPC142165 |
0.9635 | High Similarity | NPC284556 |
0.9635 | High Similarity | NPC301178 |
0.9565 | High Similarity | NPC119663 |
0.9565 | High Similarity | NPC471417 |
0.9504 | High Similarity | NPC80710 |
0.9504 | High Similarity | NPC194653 |
0.9504 | High Similarity | NPC203747 |
0.9504 | High Similarity | NPC139364 |
0.9504 | High Similarity | NPC254702 |
0.9496 | High Similarity | NPC105213 |
0.9437 | High Similarity | NPC195763 |
0.9437 | High Similarity | NPC264289 |
0.9437 | High Similarity | NPC200060 |
0.9437 | High Similarity | NPC92722 |
0.9437 | High Similarity | NPC333691 |
0.9437 | High Similarity | NPC264550 |
0.9437 | High Similarity | NPC139293 |
0.9437 | High Similarity | NPC102003 |
0.9437 | High Similarity | NPC142876 |
0.9437 | High Similarity | NPC40290 |
0.9437 | High Similarity | NPC69430 |
0.9424 | High Similarity | NPC287722 |
0.9407 | High Similarity | NPC208760 |
0.9371 | High Similarity | NPC472279 |
0.9366 | High Similarity | NPC287395 |
0.9366 | High Similarity | NPC183655 |
0.9366 | High Similarity | NPC131451 |
0.9366 | High Similarity | NPC15329 |
0.9362 | High Similarity | NPC12377 |
0.9348 | High Similarity | NPC50823 |
0.9306 | High Similarity | NPC256406 |
0.9306 | High Similarity | NPC31363 |
0.9306 | High Similarity | NPC78505 |
0.9301 | High Similarity | NPC287101 |
0.9301 | High Similarity | NPC52005 |
0.9301 | High Similarity | NPC223579 |
0.9301 | High Similarity | NPC183950 |
0.9301 | High Similarity | NPC137062 |
0.9296 | High Similarity | NPC93034 |
0.9296 | High Similarity | NPC125449 |
0.9296 | High Similarity | NPC188074 |
0.9296 | High Similarity | NPC119660 |
0.9241 | High Similarity | NPC245382 |
0.9241 | High Similarity | NPC39732 |
0.9241 | High Similarity | NPC181209 |
0.9241 | High Similarity | NPC100263 |
0.9241 | High Similarity | NPC304954 |
0.9241 | High Similarity | NPC35763 |
0.9241 | High Similarity | NPC269451 |
0.9241 | High Similarity | NPC257648 |
0.9241 | High Similarity | NPC60972 |
0.9241 | High Similarity | NPC121522 |
0.9241 | High Similarity | NPC131266 |
0.9241 | High Similarity | NPC216769 |
0.9241 | High Similarity | NPC477231 |
0.9241 | High Similarity | NPC55205 |
0.9241 | High Similarity | NPC100971 |
0.9241 | High Similarity | NPC291802 |
0.9241 | High Similarity | NPC209487 |
0.9236 | High Similarity | NPC29231 |
0.9231 | High Similarity | NPC120464 |
0.9231 | High Similarity | NPC474903 |
0.922 | High Similarity | NPC242893 |
0.922 | High Similarity | NPC38065 |
0.9203 | High Similarity | NPC44573 |
0.9179 | High Similarity | NPC247779 |
0.9179 | High Similarity | NPC66905 |
0.9178 | High Similarity | NPC469550 |
0.9178 | High Similarity | NPC124714 |
0.9172 | High Similarity | NPC252933 |
0.9172 | High Similarity | NPC45291 |
0.9172 | High Similarity | NPC19980 |
0.9172 | High Similarity | NPC200740 |
0.9172 | High Similarity | NPC54394 |
0.9172 | High Similarity | NPC125062 |
0.9172 | High Similarity | NPC272566 |
0.9167 | High Similarity | NPC48479 |
0.9167 | High Similarity | NPC38545 |
0.9167 | High Similarity | NPC177298 |
0.9167 | High Similarity | NPC171916 |
0.9161 | High Similarity | NPC168803 |
0.9161 | High Similarity | NPC95864 |
0.9161 | High Similarity | NPC108406 |
0.9161 | High Similarity | NPC12200 |
0.9149 | High Similarity | NPC16353 |
0.9137 | High Similarity | NPC4796 |
0.913 | High Similarity | NPC473391 |
0.913 | High Similarity | NPC472364 |
0.9116 | High Similarity | NPC152951 |
0.9116 | High Similarity | NPC57674 |
0.9116 | High Similarity | NPC39184 |
0.9116 | High Similarity | NPC20830 |
0.9116 | High Similarity | NPC2928 |
0.9116 | High Similarity | NPC234255 |
0.9116 | High Similarity | NPC117992 |
0.9116 | High Similarity | NPC256612 |
0.9116 | High Similarity | NPC230149 |
0.9116 | High Similarity | NPC168247 |
0.9116 | High Similarity | NPC38898 |
0.911 | High Similarity | NPC25270 |
0.911 | High Similarity | NPC100887 |
0.911 | High Similarity | NPC239128 |
0.911 | High Similarity | NPC198826 |
0.911 | High Similarity | NPC82325 |
0.911 | High Similarity | NPC120163 |
0.911 | High Similarity | NPC71334 |
0.911 | High Similarity | NPC131624 |
0.911 | High Similarity | NPC212678 |
0.911 | High Similarity | NPC275722 |
0.911 | High Similarity | NPC187498 |
0.911 | High Similarity | NPC57030 |
0.911 | High Similarity | NPC219582 |
0.911 | High Similarity | NPC222830 |
0.911 | High Similarity | NPC156222 |
0.911 | High Similarity | NPC301323 |
0.911 | High Similarity | NPC241498 |
0.911 | High Similarity | NPC260979 |
0.911 | High Similarity | NPC236637 |
0.911 | High Similarity | NPC83508 |
0.911 | High Similarity | NPC256283 |
0.911 | High Similarity | NPC302950 |
0.911 | High Similarity | NPC279989 |
0.911 | High Similarity | NPC162313 |
0.911 | High Similarity | NPC293183 |
0.911 | High Similarity | NPC275836 |
0.911 | High Similarity | NPC472912 |
0.911 | High Similarity | NPC188203 |
0.9103 | High Similarity | NPC10467 |
0.9103 | High Similarity | NPC85131 |
0.9103 | High Similarity | NPC156953 |
0.9097 | High Similarity | NPC203077 |
0.9097 | High Similarity | NPC196277 |
0.9097 | High Similarity | NPC195202 |
0.9097 | High Similarity | NPC166036 |
0.9097 | High Similarity | NPC43669 |
0.9097 | High Similarity | NPC107636 |
0.9097 | High Similarity | NPC238279 |
0.9097 | High Similarity | NPC272721 |
0.9091 | High Similarity | NPC143903 |
0.9091 | High Similarity | NPC226987 |
0.9078 | High Similarity | NPC299154 |
0.9054 | High Similarity | NPC472455 |
0.9054 | High Similarity | NPC472916 |
0.9054 | High Similarity | NPC265511 |
0.9048 | High Similarity | NPC227337 |
0.9048 | High Similarity | NPC274327 |
0.9048 | High Similarity | NPC47781 |
0.9048 | High Similarity | NPC160951 |
0.9048 | High Similarity | NPC78326 |
0.9048 | High Similarity | NPC273462 |
0.9048 | High Similarity | NPC292214 |
0.9048 | High Similarity | NPC236223 |
0.9048 | High Similarity | NPC179126 |
0.9048 | High Similarity | NPC271779 |
0.9048 | High Similarity | NPC270620 |
0.9048 | High Similarity | NPC88645 |
0.9048 | High Similarity | NPC145379 |
0.9048 | High Similarity | NPC49402 |
0.9048 | High Similarity | NPC33051 |
0.9048 | High Similarity | NPC250557 |
0.9048 | High Similarity | NPC22519 |
0.9048 | High Similarity | NPC70433 |
0.9048 | High Similarity | NPC255350 |
0.9048 | High Similarity | NPC167091 |
0.9048 | High Similarity | NPC176775 |
0.9048 | High Similarity | NPC206238 |
0.9048 | High Similarity | NPC231018 |
0.9048 | High Similarity | NPC183878 |
0.9048 | High Similarity | NPC69394 |
0.9048 | High Similarity | NPC18727 |
0.9044 | High Similarity | NPC128348 |
0.9044 | High Similarity | NPC309717 |
0.9044 | High Similarity | NPC189106 |
0.9044 | High Similarity | NPC112192 |
0.9044 | High Similarity | NPC164236 |
0.9044 | High Similarity | NPC66384 |
0.9041 | High Similarity | NPC133953 |
0.9041 | High Similarity | NPC260895 |
0.9041 | High Similarity | NPC308451 |
0.9041 | High Similarity | NPC28274 |
0.9041 | High Similarity | NPC262623 |
0.9041 | High Similarity | NPC50403 |
0.9034 | High Similarity | NPC270465 |
0.9034 | High Similarity | NPC87125 |
0.9034 | High Similarity | NPC105512 |
0.9034 | High Similarity | NPC159103 |
0.9028 | High Similarity | NPC77378 |
0.9028 | High Similarity | NPC77598 |
0.9028 | High Similarity | NPC62536 |
0.9028 | High Similarity | NPC33265 |
0.9021 | High Similarity | NPC70136 |
0.9014 | High Similarity | NPC50954 |
0.8993 | High Similarity | NPC291508 |
0.8993 | High Similarity | NPC472963 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC110419 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.911 | High Similarity | NPD1934 | Approved |
0.9054 | High Similarity | NPD3882 | Suspended |
0.9048 | High Similarity | NPD2801 | Approved |
0.8951 | High Similarity | NPD1511 | Approved |
0.8828 | High Similarity | NPD1512 | Approved |
0.8792 | High Similarity | NPD2393 | Clinical (unspecified phase) |
0.8768 | High Similarity | NPD1240 | Approved |
0.8652 | High Similarity | NPD1510 | Phase 2 |
0.8643 | High Similarity | NPD1607 | Approved |
0.8633 | High Similarity | NPD943 | Approved |
0.8553 | High Similarity | NPD4868 | Clinical (unspecified phase) |
0.8526 | High Similarity | NPD6168 | Clinical (unspecified phase) |
0.8526 | High Similarity | NPD6166 | Phase 2 |
0.8526 | High Similarity | NPD6167 | Clinical (unspecified phase) |
0.8487 | Intermediate Similarity | NPD3817 | Phase 2 |
0.844 | Intermediate Similarity | NPD230 | Phase 1 |
0.8418 | Intermediate Similarity | NPD3818 | Discontinued |
0.8406 | Intermediate Similarity | NPD9494 | Approved |
0.8389 | Intermediate Similarity | NPD6980 | Clinical (unspecified phase) |
0.8382 | Intermediate Similarity | NPD4379 | Clinical (unspecified phase) |
0.8365 | Intermediate Similarity | NPD7054 | Approved |
0.8345 | Intermediate Similarity | NPD1549 | Phase 2 |
0.8344 | Intermediate Similarity | NPD4380 | Phase 2 |
0.8313 | Intermediate Similarity | NPD7074 | Phase 3 |
0.8313 | Intermediate Similarity | NPD7472 | Approved |
0.8311 | Intermediate Similarity | NPD6799 | Approved |
0.8301 | Intermediate Similarity | NPD1465 | Phase 2 |
0.8286 | Intermediate Similarity | NPD3027 | Phase 3 |
0.828 | Intermediate Similarity | NPD6232 | Discontinued |
0.8276 | Intermediate Similarity | NPD1552 | Clinical (unspecified phase) |
0.8276 | Intermediate Similarity | NPD1550 | Clinical (unspecified phase) |
0.8255 | Intermediate Similarity | NPD4378 | Clinical (unspecified phase) |
0.8239 | Intermediate Similarity | NPD7473 | Discontinued |
0.8219 | Intermediate Similarity | NPD970 | Clinical (unspecified phase) |
0.8148 | Intermediate Similarity | NPD6797 | Phase 2 |
0.8141 | Intermediate Similarity | NPD7075 | Discontinued |
0.8108 | Intermediate Similarity | NPD3750 | Approved |
0.8098 | Intermediate Similarity | NPD7251 | Discontinued |
0.8085 | Intermediate Similarity | NPD1529 | Clinical (unspecified phase) |
0.8082 | Intermediate Similarity | NPD2796 | Approved |
0.8065 | Intermediate Similarity | NPD7096 | Clinical (unspecified phase) |
0.8049 | Intermediate Similarity | NPD4338 | Clinical (unspecified phase) |
0.8049 | Intermediate Similarity | NPD7808 | Phase 3 |
0.8038 | Intermediate Similarity | NPD5494 | Approved |
0.8037 | Intermediate Similarity | NPD7993 | Clinical (unspecified phase) |
0.8025 | Intermediate Similarity | NPD4381 | Clinical (unspecified phase) |
0.8025 | Intermediate Similarity | NPD5844 | Phase 1 |
0.8014 | Intermediate Similarity | NPD651 | Clinical (unspecified phase) |
0.8014 | Intermediate Similarity | NPD1530 | Clinical (unspecified phase) |
0.8013 | Intermediate Similarity | NPD7410 | Clinical (unspecified phase) |
0.7987 | Intermediate Similarity | NPD6599 | Discontinued |
0.7986 | Intermediate Similarity | NPD1613 | Approved |
0.7986 | Intermediate Similarity | NPD1612 | Clinical (unspecified phase) |
0.7972 | Intermediate Similarity | NPD6859 | Clinical (unspecified phase) |
0.7959 | Intermediate Similarity | NPD2935 | Discontinued |
0.7949 | Intermediate Similarity | NPD7819 | Suspended |
0.7947 | Intermediate Similarity | NPD6143 | Clinical (unspecified phase) |
0.7914 | Intermediate Similarity | NPD9269 | Phase 2 |
0.7888 | Intermediate Similarity | NPD3926 | Phase 2 |
0.7885 | Intermediate Similarity | NPD6801 | Discontinued |
0.7868 | Intermediate Similarity | NPD5536 | Phase 2 |
0.7867 | Intermediate Similarity | NPD1878 | Clinical (unspecified phase) |
0.7867 | Intermediate Similarity | NPD4628 | Phase 3 |
0.7862 | Intermediate Similarity | NPD919 | Approved |
0.7838 | Intermediate Similarity | NPD1551 | Phase 2 |
0.7821 | Intermediate Similarity | NPD7411 | Suspended |
0.7808 | Intermediate Similarity | NPD447 | Suspended |
0.78 | Intermediate Similarity | NPD7421 | Clinical (unspecified phase) |
0.7785 | Intermediate Similarity | NPD8443 | Clinical (unspecified phase) |
0.777 | Intermediate Similarity | NPD3748 | Approved |
0.7764 | Intermediate Similarity | NPD1247 | Approved |
0.7762 | Intermediate Similarity | NPD3018 | Phase 2 |
0.7712 | Intermediate Similarity | NPD4357 | Discontinued |
0.7697 | Intermediate Similarity | NPD6190 | Approved |
0.7687 | Intermediate Similarity | NPD228 | Approved |
0.7677 | Intermediate Similarity | NPD5403 | Approved |
0.7673 | Intermediate Similarity | NPD5402 | Approved |
0.7662 | Intermediate Similarity | NPD5401 | Approved |
0.7654 | Intermediate Similarity | NPD7199 | Phase 2 |
0.7651 | Intermediate Similarity | NPD1509 | Clinical (unspecified phase) |
0.764 | Intermediate Similarity | NPD6234 | Discontinued |
0.7635 | Intermediate Similarity | NPD6651 | Approved |
0.7626 | Intermediate Similarity | NPD9268 | Approved |
0.7606 | Intermediate Similarity | NPD2983 | Phase 2 |
0.7606 | Intermediate Similarity | NPD2982 | Phase 2 |
0.76 | Intermediate Similarity | NPD6100 | Approved |
0.76 | Intermediate Similarity | NPD6099 | Approved |
0.759 | Intermediate Similarity | NPD7804 | Clinical (unspecified phase) |
0.7578 | Intermediate Similarity | NPD3749 | Approved |
0.7568 | Intermediate Similarity | NPD1933 | Approved |
0.7566 | Intermediate Similarity | NPD2800 | Approved |
0.7561 | Intermediate Similarity | NPD5242 | Approved |
0.7561 | Intermediate Similarity | NPD7184 | Clinical (unspecified phase) |
0.756 | Intermediate Similarity | NPD6559 | Discontinued |
0.7554 | Intermediate Similarity | NPD9545 | Approved |
0.755 | Intermediate Similarity | NPD2344 | Approved |
0.7548 | Intermediate Similarity | NPD2534 | Approved |
0.7548 | Intermediate Similarity | NPD2532 | Approved |
0.7548 | Intermediate Similarity | NPD2533 | Approved |
0.7547 | Intermediate Similarity | NPD37 | Approved |
0.7546 | Intermediate Similarity | NPD6959 | Discontinued |
0.7535 | Intermediate Similarity | NPD3972 | Approved |
0.7535 | Intermediate Similarity | NPD2981 | Phase 2 |
0.7516 | Intermediate Similarity | NPD1653 | Approved |
0.7516 | Intermediate Similarity | NPD7768 | Phase 2 |
0.7515 | Intermediate Similarity | NPD7852 | Clinical (unspecified phase) |
0.75 | Intermediate Similarity | NPD1203 | Approved |
0.7485 | Intermediate Similarity | NPD8055 | Clinical (unspecified phase) |
0.7484 | Intermediate Similarity | NPD6386 | Approved |
0.7484 | Intermediate Similarity | NPD6385 | Approved |
0.7465 | Intermediate Similarity | NPD422 | Phase 1 |
0.7456 | Intermediate Similarity | NPD7685 | Pre-registration |
0.7453 | Intermediate Similarity | NPD5353 | Approved |
0.7451 | Intermediate Similarity | NPD1243 | Approved |
0.7429 | Intermediate Similarity | NPD1548 | Phase 1 |
0.7413 | Intermediate Similarity | NPD1608 | Approved |
0.7407 | Intermediate Similarity | NPD4966 | Approved |
0.7407 | Intermediate Similarity | NPD4965 | Approved |
0.7407 | Intermediate Similarity | NPD4967 | Phase 2 |
0.7403 | Intermediate Similarity | NPD6398 | Clinical (unspecified phase) |
0.7358 | Intermediate Similarity | NPD7458 | Discontinued |
0.7356 | Intermediate Similarity | NPD8397 | Clinical (unspecified phase) |
0.7355 | Intermediate Similarity | NPD2309 | Approved |
0.7347 | Intermediate Similarity | NPD4908 | Phase 1 |
0.7343 | Intermediate Similarity | NPD1610 | Phase 2 |
0.7342 | Intermediate Similarity | NPD920 | Approved |
0.7338 | Intermediate Similarity | NPD2654 | Approved |
0.7329 | Intermediate Similarity | NPD2798 | Approved |
0.7321 | Intermediate Similarity | NPD3751 | Discontinued |
0.7321 | Intermediate Similarity | NPD7228 | Approved |
0.7319 | Intermediate Similarity | NPD5283 | Phase 1 |
0.731 | Intermediate Similarity | NPD1876 | Approved |
0.7308 | Intermediate Similarity | NPD643 | Clinical (unspecified phase) |
0.7303 | Intermediate Similarity | NPD2799 | Discontinued |
0.7303 | Intermediate Similarity | NPD4308 | Phase 3 |
0.7294 | Intermediate Similarity | NPD5953 | Discontinued |
0.7292 | Intermediate Similarity | NPD9717 | Approved |
0.7286 | Intermediate Similarity | NPD9493 | Approved |
0.7278 | Intermediate Similarity | NPD7501 | Clinical (unspecified phase) |
0.7261 | Intermediate Similarity | NPD7390 | Discontinued |
0.725 | Intermediate Similarity | NPD3226 | Approved |
0.725 | Intermediate Similarity | NPD824 | Approved |
0.725 | Intermediate Similarity | NPD3455 | Phase 2 |
0.7248 | Intermediate Similarity | NPD4907 | Clinical (unspecified phase) |
0.7248 | Intermediate Similarity | NPD3764 | Approved |
0.7248 | Intermediate Similarity | NPD3268 | Approved |
0.7244 | Intermediate Similarity | NPD2354 | Approved |
0.723 | Intermediate Similarity | NPD6832 | Phase 2 |
0.7219 | Intermediate Similarity | NPD1899 | Clinical (unspecified phase) |
0.7215 | Intermediate Similarity | NPD642 | Clinical (unspecified phase) |
0.7208 | Intermediate Similarity | NPD3540 | Phase 1 |
0.7208 | Intermediate Similarity | NPD7266 | Discontinued |
0.7203 | Intermediate Similarity | NPD17 | Approved |
0.7194 | Intermediate Similarity | NPD1241 | Discontinued |
0.7192 | Intermediate Similarity | NPD3225 | Approved |
0.7176 | Intermediate Similarity | NPD7286 | Phase 2 |
0.7152 | Intermediate Similarity | NPD1558 | Phase 1 |
0.7143 | Intermediate Similarity | NPD1470 | Approved |
0.7143 | Intermediate Similarity | NPD2797 | Approved |
0.7143 | Intermediate Similarity | NPD3539 | Phase 1 |
0.7134 | Intermediate Similarity | NPD4288 | Approved |
0.7133 | Intermediate Similarity | NPD2313 | Discontinued |
0.7133 | Intermediate Similarity | NPD411 | Approved |
0.7133 | Intermediate Similarity | NPD6798 | Discontinued |
0.7118 | Intermediate Similarity | NPD2163 | Approved |
0.711 | Intermediate Similarity | NPD4419 | Clinical (unspecified phase) |
0.7107 | Intermediate Similarity | NPD7004 | Clinical (unspecified phase) |
0.7105 | Intermediate Similarity | NPD6355 | Discontinued |
0.7103 | Intermediate Similarity | NPD1547 | Clinical (unspecified phase) |
0.7103 | Intermediate Similarity | NPD1201 | Approved |
0.7097 | Intermediate Similarity | NPD2346 | Discontinued |
0.7083 | Intermediate Similarity | NPD3787 | Discontinued |
0.7079 | Intermediate Similarity | NPD7879 | Clinical (unspecified phase) |
0.7075 | Intermediate Similarity | NPD1283 | Approved |
0.707 | Intermediate Similarity | NPD7003 | Approved |
0.707 | Intermediate Similarity | NPD8166 | Discontinued |
0.7067 | Intermediate Similarity | NPD4625 | Phase 3 |
0.7055 | Intermediate Similarity | NPD5090 | Approved |
0.7055 | Intermediate Similarity | NPD5089 | Approved |
0.7048 | Intermediate Similarity | NPD6971 | Discontinued |
0.7039 | Intermediate Similarity | NPD4307 | Phase 2 |
0.7039 | Intermediate Similarity | NPD4060 | Phase 1 |
0.703 | Intermediate Similarity | NPD5978 | Approved |
0.703 | Intermediate Similarity | NPD5977 | Approved |
0.7029 | Intermediate Similarity | NPD3022 | Approved |
0.7029 | Intermediate Similarity | NPD3021 | Approved |
0.7027 | Intermediate Similarity | NPD3267 | Approved |
0.7027 | Intermediate Similarity | NPD3266 | Approved |
0.702 | Intermediate Similarity | NPD1296 | Phase 2 |
0.7014 | Intermediate Similarity | NPD1651 | Approved |
0.7007 | Intermediate Similarity | NPD4749 | Approved |
0.7007 | Intermediate Similarity | NPD9265 | Clinical (unspecified phase) |
0.7 | Intermediate Similarity | NPD7422 | Clinical (unspecified phase) |
0.6988 | Remote Similarity | NPD5019 | Clinical (unspecified phase) |
0.6987 | Remote Similarity | NPD2355 | Clinical (unspecified phase) |
0.6987 | Remote Similarity | NPD2353 | Approved |
0.6982 | Remote Similarity | NPD5711 | Approved |
0.6982 | Remote Similarity | NPD5710 | Approved |
0.6974 | Remote Similarity | NPD6233 | Phase 2 |
0.6971 | Remote Similarity | NPD3534 | Clinical (unspecified phase) |
PubChem CID   | 5318999 |
ChEMBL   | CHEMBL2437372 |
ZINC   |
Molecular Weight:   | 286.08 |
ALogP:   | -1.3354 |
MLogP:   | 2.67 |
XLogP:   | 2.109 |
# Rotatable Bonds:   | 8 |
Polar Surface Area:   | 86.99 |
# H-Bond Aceptor:   | 1 |
# H-Bond Donor:   | 3 |
# Rings:   | 2 |
# Heavy Atoms:   | 21 |